These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12142344)

  • 1. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice.
    Mehrabian M; Allayee H; Wong J; Shi W; Wang XP; Shaposhnik Z; Funk CD; Lusis AJ
    Circ Res; 2002 Jul; 91(2):120-6. PubMed ID: 12142344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice.
    Ghazalpour A; Wang X; Lusis AJ; Mehrabian M
    Genetics; 2006 Jun; 173(2):943-51. PubMed ID: 16624897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid differences in the deduced 5-lipoxygenase sequence of CAST atherosclerosis-resistance mice confer impaired activity when introduced into the human ortholog.
    Kuhn H; Anton M; Gerth C; Habenicht A
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1072-6. PubMed ID: 12730086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia.
    Mehrabian M; Wong J; Wang X; Jiang Z; Shi W; Fogelman AM; Lusis AJ
    Circ Res; 2001 Jul; 89(2):125-30. PubMed ID: 11463718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.
    Huo Y; Zhao L; Hyman MC; Shashkin P; Harry BL; Burcin T; Forlow SB; Stark MA; Smith DF; Clarke S; Srinivasan S; Hedrick CC; Praticò D; Witztum JL; Nadler JL; Funk CD; Ley K
    Circulation; 2004 Oct; 110(14):2024-31. PubMed ID: 15451785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice.
    Cyrus T; Praticò D; Zhao L; Witztum JL; Rader DJ; Rokach J; FitzGerald GA; Funk CD
    Circulation; 2001 May; 103(18):2277-82. PubMed ID: 11342477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice.
    George J; Afek A; Shaish A; Levkovitz H; Bloom N; Cyrus T; Zhao L; Funk CD; Sigal E; Harats D
    Circulation; 2001 Oct; 104(14):1646-50. PubMed ID: 11581143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model.
    Welch CL; Bretschger S; Latib N; Bezouevski M; Guo Y; Pleskac N; Liang CP; Barlow C; Dansky H; Breslow JL; Tall AR
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7946-51. PubMed ID: 11438740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of chromosome 2 obesity loci on cardiovascular complications of insulin resistance in LDL receptor-deficient C57BL/6 mice.
    Estrada-Smith D; Collins AR; Wang X; Crockett C; Castellani L; Lusis AJ; Davis RC
    Diabetes; 2006 Aug; 55(8):2265-71. PubMed ID: 16873689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice.
    Burleigh ME; Babaev VR; Oates JA; Harris RC; Gautam S; Riendeau D; Marnett LJ; Morrow JD; Fazio S; Linton MF
    Circulation; 2002 Apr; 105(15):1816-23. PubMed ID: 11956125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative trait locus mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice: identification of a locus for metabolic syndrome and increased atherosclerosis on chromosome 4.
    Seidelmann SB; De Luca C; Leibel RL; Breslow JL; Tall AR; Welch CL
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):204-10. PubMed ID: 15514201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice.
    Harats D; Shaish A; George J; Mulkins M; Kurihara H; Levkovitz H; Sigal E
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2100-5. PubMed ID: 10978255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican.
    Seidelmann SB; Kuo C; Pleskac N; Molina J; Sayers S; Li R; Zhou J; Johnson P; Braun K; Chan C; Teupser D; Breslow JL; Wight TN; Tall AR; Welch CL
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2180-6. PubMed ID: 18818413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.
    Fazio S; Major AS; Swift LL; Gleaves LA; Accad M; Linton MF; Farese RV
    J Clin Invest; 2001 Jan; 107(2):163-71. PubMed ID: 11160132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.
    Accad M; Smith SJ; Newland DL; Sanan DA; King LE; Linton MF; Fazio S; Farese RV
    J Clin Invest; 2000 Mar; 105(6):711-9. PubMed ID: 10727439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of Ath26 locus on chromosome 17 and identification of Cyp4f13 as an atherosclerosis modifying gene.
    Han J; Robinet P; Ritchey B; Andro H; Smith JD
    Atherosclerosis; 2019 Jul; 286():71-78. PubMed ID: 31102955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice.
    Choi JH; Jeon HJ; Park JG; Sonn SK; Lee MR; Lee MN; You HJ; Kim GY; Kim JH; Lee MH; Kwon OS; Nam KH; Kim HC; Jeong TS; Lee WS; Oh GT
    Atherosclerosis; 2010 Sep; 212(1):146-52. PubMed ID: 20684827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient mice.
    Holdt LM; Thiery J; Breslow JL; Teupser D
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1097-103. PubMed ID: 18356551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.